1. Home
  2. VRCA vs YRD Comparison

VRCA vs YRD Comparison

Compare VRCA & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$3.78

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

HOLD

Current Price

$0.78

Market Cap

88.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRCA
YRD
Founded
2013
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.0M
88.4M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
VRCA
YRD
Price
$3.78
$0.78
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $13.83
N/A
AVG Volume (30 Days)
44.6K
★ 1.9M
Earning Date
11-13-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $35,577,000.00
N/A
Revenue This Year
N/A
$426.63
Revenue Next Year
$58.01
N/A
P/E Ratio
★ N/A
$1.86
Revenue Growth
★ 370.22
N/A
52 Week Low
$3.28
$0.36
52 Week High
$9.82
$6.10

Technical Indicators

Market Signals
Indicator
VRCA
YRD
Relative Strength Index (RSI) 35.23 43.21
Support Level N/A N/A
Resistance Level $5.94 $1.05
Average True Range (ATR) 0.35 0.11
MACD -0.05 -0.03
Stochastic Oscillator 19.48 60.97

Price Performance

Historical Comparison
VRCA
YRD

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: